Putting patients first. Always.

Find Out More

Partnering in drug delivery devices. Holistically.

Find Out More

Going the extra-mile. Together.

Find Out More

Our vision is to become the most patient-centric drug delivery device solutions company.

We design and manufacture drug delivery device solutions that maximize treatment efficacy and partner with our customers in their device strategies, to ultimately bring high quality and safe treatment solutions to patients.

At Nemera, we put patients first!

Our broad offering

Our products

Nemera proprietary drug delivery services.

As a fast growing, modern company, we strive to deliver the right product at the right time.
We provide a wide range of devices covering the major delivery routes: ophthalmic, ear, nose, throat, dermal, parenteral, inhalation, oral, vaginal, rectal.

Find Out More

Our services

Contract Development and manufacturing services.

From design research to full development of innovative device solutions, we help you drive better healthcare outcomes for your patients.
We provide end-to-end services and expertise in device development, device consulting, and contract manufacturing to complement our diverse portfolio of products and to help you through every step of the journey.

 

Find Out More
Preclinical builds-Clinical trials support-services

Our capabilities

Holistic end-to-end know-how

We are agile and flexible to be able to meet specific customer needs, while constantly innovating and improving.
The expertise of everyone who works at Nemera enables us to establish very strong relationships with our customers, while maintaining growth and innovation.

Find Out More
User Experience Design-Insight Capabilities-Services

Our news

Focus on injectables in the ‘Pharmaceutical Post’

Severine Duband, our Marketing Director was interviewed by the journalist of the 'Pharmaceutical Post', to talk about Symbioze and how we developed the product. The main challenge for manufacturers is…
Continue Reading
marketing interview - october 2021 - press marketing interview - october 2021 - press

A new ENT device: UniSpray

We are happy to announce the launch of Unispray, our unidose system primarily for systemic-acting drug administration.
Continue Reading

Nemera joins IPAC-RS as an Associate Member

Nemera is excited to announce that it has become an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS)
Continue Reading